Market Tracker

11/27 11:45am ET

Repligen Corp (NASDAQ:RGEN)

23.17
Data as of Nov 26
 +0.43 / +1.89%
Today’s Change
11.70
Today|||52-Week Range
26.75
+69.87%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close22.74
Today’s open22.62
Day’s range22.47 - 23.27
Volume249,018
Average volume (3 months)380,145
Market cap$758.2M
Dividend yield--
Data as of 4:00pm ET, 11/26/2014

Growth & Valuation

Earnings growth (last year)+11.11%
Earnings growth (this year)-47.33%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+9.48%
P/E ratio64.4
Price/Sales6.34
Price/Book7.12

Competitors

 Today’s
change
Today’s
% change
OMEROmeros Corp+0.58+2.66%
FOLDAmicus Therapeutics ...+0.18+2.26%
EPZMEpizyme Inc+0.64+2.92%
TTPHTetraphase Pharmaceu...+1.76+7.32%
Data as of 4:00pm ET, 11/26/2014

Financials

Next reporting dateMarch 5, 2015
EPS forecast (this quarter)$0.03
Annual revenue (last year)$68.2M
Annual profit (last year)$16.1M
Net profit margin23.61%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President, CEO, Treasurer, Director &
CAO
Walter C. Herlihy
Chief Operating Officer
Tony J. Hunt
Corporate headquarters
Waltham, Massachusetts

Forecasts